TWD
COGT icon

True Wealth Design’s Cogent Biosciences COGT Stock Holding History

True Wealth Design’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97K Buy
+51
New +$1.78K ﹤0.01% 1696
2025
Q2 		– Sell
-277
Closed -$1.66K – 2632
2025
Q1 		$1.66K Buy
+277
New +$2.17K ﹤0.01% 1078

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

True Wealth Design's COGT Position: Q2 2026 in Review

True Wealth Design opened a new position in Cogent Biosciences (COGT) in Q2 2026: 51 shares worth $1.97K. The stake represents ﹤0.01% of the portfolio and ranks #1696 among its holdings. This is a return to the name: True Wealth Design previously reported a position in COGT as recently as Q1 2025.

True Wealth Design first reported a position in COGT in Q1 2025 and has held it in 2 quarters since. 18 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • True Wealth Design held 51 shares of Cogent Biosciences worth $1.97K as of Q2 2026.
  • Cogent Biosciences was a new True Wealth Design position in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1696 holding.
  • True Wealth Design first reported a position in Cogent Biosciences in Q1 2025 and has held it in 2 quarters since.
  • 18 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.